Evaluation of GABAergic Transmission Modulation as a Novel Functional Target for Management of Multiple Sclerosis: Exploring Inhibitory Effect of GABA on Glutamate-Mediated Excitotoxicity
Figure 1
Changes in neurological/clinical signs of EAE with days after immunization. Significant difference was found in the mean clinical scores (±SEM), [] of animals of phenobarbitone (T-2) and sodium valproate (T-3) groups as compared to the diseased control group, [ by one way ANOVA (Dunnett’s multiple comparisons test)].